BML-190
|
|
BML-190 Eigenschaften
- Schmelzpunkt:
- 162.0-163.5 °C
- Siedepunkt:
- 586.7±50.0 °C(Predicted)
- Dichte
- 1.31
- storage temp.
- Sealed in dry,Store in freezer, under -20°C
- L?slichkeit
- DMSO: >20mg/mL
- Aggregatzustand
- solid
- pka
- -0.97±0.20(Predicted)
- Farbe
- off-white
Sicherheit
WGK Germany | 3 | ||
---|---|---|---|
Toxizit?t | rat,LDLo,oral,40mg/kg (40mg/kg),Bollettino Chimico Farmaceutico. Vol. 114, Pg. 309, 1975. |
BML-190 Chemische Eigenschaften,Einsatz,Produktion Methoden
Biologische Aktivit?t
Potent and selective CB 2 receptor ligand (K i values are 435 nM and > 2 μ M for CB 2 and CB 1 respectively).BML-190 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
BML-190 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 114)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Hubei Jusheng Technology Co.,Ltd. | 18871490254 |
linda@hubeijusheng.com | CHINA | 28172 | 58 |
Alchem Pharmtech,Inc. | 8485655694 |
sales@alchempharmtech.com | United States | 63687 | 58 |
CONIER CHEM AND PHARMA LIMITED | +8618523575427 |
sales@conier.com | China | 49374 | 58 |
career henan chemical co | +86-0371-86658258 +8613203830695 |
factory@coreychem.com | China | 29810 | 58 |
Shanghai UCHEM Inc. | +862156762820 +86-13564624040 |
sales@myuchem.com | China | 7709 | 58 |
Dideu Industries Group Limited | +86-29-89586680 +86-15129568250 |
1026@dideu.com | China | 22787 | 58 |
BOC Sciences | 16314854226; +16314854226 |
inquiry@bocsci.com | United States | 19741 | 58 |
Hefei Hirisun Pharmatech Co., Ltd | +8615056975894 |
shawn@hirisunpharm.com | CHINA | 9911 | 58 |
InvivoChem | +1-708-310-1919 +1-13798911105 |
sales@invivochem.cn | United States | 6391 | 58 |
Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 |
sales@molcore.com | China | 49734 | 58 |
2854-32-2()Verwandte Suche:
Indol-3-ylessigsure
5-Methoxy-N,N-dimethyl-1H-indol-3-ethylamin
3-[2-(Dimethylamino)ethyl]-1H-indol-5-ol
2-(5-Methoxyindol-3-yl)ethylamin
- 1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1-[2-(4-MORPHOLINYL)-2-OXOETHYL]-1H-INDOLE
- 1h-indole,1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1-(2-(4-morpholinyl)-2-oxoe
- 4-((2-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl)acetyl)-morpholin
- BML-190, N-[1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetyl]morpholine
- 1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1-[2-(morpholinyl)-2-oxoethyl]-1H-indole
- 2-(1-(4-chlorobenzoyl)-5-Methoxy-2-Methyl-1H-indol-3-yl)-1-Morpholinoethanone
- 1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-3-[2-(4-morpholinyl)-2-oxoethyl]-1H-indole
- 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-[(morpholinocarbonyl)methyl]-indole
- 2-[1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(4-morpholinyl)ethanone
- Ethanone, 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(4-morpholinyl)-
- N-[1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetyl]morpholine
- IMMA
- INDOMETHACIN MORPHOLINYLAMIDE
- BML-190
- 1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOLE-3-ACETIC ACID, MORPHOLINEAMIDE
- BML-190 (Indomethacin morpholinylamide
- BML-190 USP/EP/BP
- Indomethacin Morpholinylamide Impurity
- BML 190; BML190; IMMA; INDOMETHACIN MORPHOLINYLAMIDE
- BML-190;BML 190;BML190
- Indomethacin morpholinamide
- 2-[1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl]-1-morpholinoethanone
- BML-190, 10 mM in DMSO
- 2854-32-2
- C23H23ClN2O4
- Inhibitors
- Cannabinoid receptor